French scientist Luc Montagnier (Luc Montagnier), which was yesterday awarded the Nobel Prize for the discovery of the AIDS virus, suggests that therapeutic vaccine for the disease appear in the next four years, reports the Mail Online. According scientists, creating a therapeutic vaccine for the treatment of HIV infection likely than the development of a vaccine. With sufficient funding therapeutic vaccine test results appear in print in the next three or four years, he said. A therapeutic vaccine for HIV-infected patients can be administered. Its application is to prevent the symptoms of AIDS, said the Nobel laureate. Luc Montagnier and his compatriot Francoise Barre-Sinoussi, also awarded the 2008 Nobel Prize in Physiology or Medicine in 1983, were able to recognize the situation and describe. The human immunodeficiency virus (HIV) infection of the lymph node biopsy patients This discovery was one prerequisite for understanding the mechanisms of disease development and the creation of anti-retroviral therapy to slow the disease, said the Nobel committee.
Tuesday, October 1, 2013
Grader died in physical education
During the race the 100 meters in physical education grader died in Kiev. A boy from the tenth grade at the school complained Health Zaporozhye, and his medical records were no health problems recorded. However, after the re-warm-up he went the distance, and then started to choke and fell before reaching the finish line. Him immediately to help physical education teacher who began CPR, and classmates as a nurse rushed. Soon arrived and "fast", but the paramedic team had a defibrillator and respirator, and nothing I could do. And when the resuscitation team arrived, the boy was already dead. To this day, the doctors are not obliged to comment on them because not completed an internal investigation. According to the deputy head of the City Council Health Neonila Chechnya, a special commission. A prosecutor at the death of the student criminal.
Blood test can determine the risk of Down syndrome in unborn babies
Developed a test in which blood test, women can decide whether the risk of a child born with Down syndrome, according to the BBC. Procedures that are currently in use, are quite aggressive and have a risk of harm to the fetus. Scientists at Stanford University have developed a test in which 18 women were able to accurately identify Down syndrome in the unborn child. The study was published in the journal PNAS. Babies with Down syndrome have an extra copy of chromosome 21, which leads to problems in the physical and mental development. The new test will be much safer with the previous one, the scientists said. A safer method helps to avoid injury to the fetus and to make an accurate diagnosis, with the wrong number of chromosomes, which is an important contribution to the diagnosis of diseases such as Down's syndrome associated to make, the scientists said.